Atherosclerosis in Rheumatoid Arthritis

by Miguel A. González-Gay, Zoltan Szekanecz, Calin D. Popa, Patrick Dessein
Published 2012-01-01

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals

by Calin D. Popa, Elke Arts, Jaap Fransen, Piet L. C. M. van Riel
Published 2012-01-01

Enhanced Cardiovascular Risk in Rheumatoid Arthritis: Elucidation, Assessment, and Management

by Patrick H. Dessein, Anne G. Semb, Miguel A. González-Gay, Calin D. Popa
Published 2015-01-01

Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis.

by Jaap Fransen, Seyyed M R Kazemi-Bajestani, Sebastian J H Bredie, Calin D Popa
Published 2016-01-01

Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study

by Dorien M. C. F. Sluijsmans, Daphne C. Rohrich, Calin D. Popa, Bart J. F. van den Bemt
Published 2021-05-01

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial

by Calin D Popa, Marian van Beers-Tas, Samina Turk, Wouter Bos, Diane Marsman, Ed N Griep, Alper van Sijl
Published 2021-04-01

Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort study

by Daphne C. Rohrich, Eline H. M. van de Wetering, Alexander J. Rennings, Elke E. Arts, Inger L. Meek, Alfons A. den Broeder, Jaap Fransen, Calin D. Popa
Published 2021-01-01

Serum Samples That Have Been Stored Long-Term (>10 Years) Can Be Used as a Suitable Data Source for Developing Cardiovascular Risk Prediction Models in Large Observational Rheumato...

by Elke E. A. Arts, Calin D. Popa, Jacqueline P. Smith, Onno J. Arntz, Fons A. van de Loo, Rogier Donders, Anne Grete P. Semb, George D. Kitas, Piet L. C. M. van Riel, Jaap Fransen
Published 2014-01-01